Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
36.94
-0.35 (-0.94%)
At close: Nov 20, 2024, 4:00 PM
36.75
-0.19 (-0.51%)
Pre-market: Nov 21, 2024, 5:50 AM EST
Moderna Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Operating Revenue | 4,964 | 6,671 | 18,435 | 17,675 | 803 | 60 | Upgrade
|
| Other Revenue | 117 | 177 | 828 | 796 | - | - | Upgrade
|
| Revenue | 5,081 | 6,848 | 19,263 | 18,471 | 803 | 60 | Upgrade
|
| Revenue Growth (YoY) | -44.29% | -64.45% | 4.29% | 2200.25% | 1238.33% | -55.58% | Upgrade
|
| Cost of Revenue | 6,481 | 9,538 | 8,711 | 4,608 | 1,378 | 496 | Upgrade
|
| Gross Profit | -1,400 | -2,690 | 10,552 | 13,863 | -575 | -436 | Upgrade
|
| Selling, General & Admin | 1,293 | 1,549 | 1,132 | 567 | 188 | 110 | Upgrade
|
| Operating Expenses | 1,293 | 1,549 | 1,132 | 567 | 188 | 110 | Upgrade
|
| Operating Income | -2,693 | -4,239 | 9,420 | 13,296 | -763 | -546 | Upgrade
|
| Interest Expense | -24 | -38 | -29 | -17 | -10 | - | Upgrade
|
| Interest & Investment Income | 437 | 421 | 200 | 18 | 25 | 39 | Upgrade
|
| Other Non Operating Income (Expenses) | -4 | -14 | 4 | -12 | 4 | -8 | Upgrade
|
| EBT Excluding Unusual Items | -2,284 | -3,870 | 9,595 | 13,285 | -744 | -515 | Upgrade
|
| Gain (Loss) on Sale of Investments | -69 | -72 | -20 | - | - | - | Upgrade
|
| Pretax Income | -2,353 | -3,942 | 9,575 | 13,285 | -744 | -515 | Upgrade
|
| Income Tax Expense | -129 | 772 | 1,213 | 1,083 | 3 | -1 | Upgrade
|
| Net Income | -2,224 | -4,714 | 8,362 | 12,202 | -747 | -514 | Upgrade
|
| Net Income to Common | -2,224 | -4,714 | 8,362 | 12,202 | -747 | -514 | Upgrade
|
| Net Income Growth | - | - | -31.47% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 383 | 382 | 394 | 403 | 381 | 331 | Upgrade
|
| Shares Outstanding (Diluted) | 383 | 382 | 416 | 431 | 381 | 331 | Upgrade
|
| Shares Change (YoY) | -0.20% | -8.17% | -3.48% | 13.12% | 15.11% | 308.07% | Upgrade
|
| EPS (Basic) | -5.81 | -12.34 | 21.22 | 30.28 | -1.96 | -1.55 | Upgrade
|
| EPS (Diluted) | -5.82 | -12.34 | 20.12 | 28.29 | -1.96 | -1.55 | Upgrade
|
| EPS Growth | - | - | -28.88% | - | - | - | Upgrade
|
| Free Cash Flow | -3,956 | -3,825 | 4,581 | 13,336 | 1,959 | -491 | Upgrade
|
| Free Cash Flow Per Share | -10.34 | -10.01 | 11.01 | 30.94 | 5.14 | -1.48 | Upgrade
|
| Gross Margin | -27.55% | -39.28% | 54.78% | 75.05% | -71.61% | - | Upgrade
|
| Operating Margin | -53.00% | -61.90% | 48.90% | 71.98% | -95.02% | -910.00% | Upgrade
|
| Profit Margin | -43.77% | -68.84% | 43.41% | 66.06% | -93.03% | -856.67% | Upgrade
|
| Free Cash Flow Margin | -77.86% | -55.86% | 23.78% | 72.20% | 243.96% | -818.33% | Upgrade
|
| EBITDA | -2,362 | -3,618 | 9,768 | 13,528 | -732 | -515 | Upgrade
|
| EBITDA Margin | -46.49% | -52.83% | 50.71% | 73.24% | -91.16% | - | Upgrade
|
| D&A For EBITDA | 331 | 621 | 348 | 232 | 31 | 31 | Upgrade
|
| EBIT | -2,693 | -4,239 | 9,420 | 13,296 | -763 | -546 | Upgrade
|
| EBIT Margin | -53.00% | -61.90% | 48.90% | 71.98% | -95.02% | - | Upgrade
|
| Effective Tax Rate | - | - | 12.67% | 8.15% | - | - | Upgrade
|
| Revenue as Reported | 5,081 | 6,848 | 19,263 | 18,471 | 803 | 60 | Upgrade
|
| Advertising Expenses | - | 204 | 121 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.